フォロー
Craig Martin
タイトル
引用先
引用先
Pharmacology of systemic antifungal agents
ESD Ashley, R Lewis, JS Lewis, C Martin, D Andes
Clinical infectious diseases 43 (Supplement_1), S28-S39, 2006
4212006
Trimethoprim‐Sulfamethoxazole as a Viable Treatment Option for Infections Caused by Methicillin‐Resistant Staphylococcus aureus
SA Grim, RP Rapp, CA Martin, ME Evans
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 25 (2 …, 2005
1272005
Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime
WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess
Antimicrobial agents and chemotherapy, AAC. 02089-16, 2016
1082016
Rhabdomyolysis during therapy with daptomycin
S Papadopoulos, AM Ball, SE Liewer, CA Martin, PS Winstead, ...
Clinical Infectious Diseases 42 (12), e108-e110, 2006
922006
Results of an antimicrobial control program at a university hospital
C Martin, I Ofotokun, R Rapp, K Empey, J Armitstead, C Pomeroy, ...
American Journal of Health-System Pharmacy 62 (7), 732-738, 2005
822005
Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness
AK Gross, SP Dunn, DJ Feola, CA Martin, R Charnigo, Z Li, A Abdel-Latif, ...
Journal of thrombosis and thrombolysis 35 (2), 147-154, 2013
732013
Therapeutic frontiers: preventing and treating infectious diseases by inhibiting bacterial quorum sensing
CA Martin, AD Hoven, AM Cook
European Journal of Clinical Microbiology & Infectious Diseases 27 (8), 635-642, 2008
662008
Voriconazole treatment of disseminated Paecilomyces infection in a patient with acquired immunodeficiency syndrome
CA Martin, S Roberts, RN Greenberg
Clinical Infectious Diseases 35 (7), e78-e81, 2002
632002
Early experience with tedizolid: clinical efficacy, pharmacodynamics, and resistance
JM Rybak, K Marx, CA Martin
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34 (11 …, 2014
562014
Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adults
AM Cook, C Martin, VR Adams, RS Morehead
Antimicrobial agents and chemotherapy 55 (7), 3240-3243, 2011
472011
Nephrotoxicity in patients with or without cystic fibrosis treated with polymyxin B compared to colistin
RL Crass, WC Rutter, DR Burgess, CA Martin, DS Burgess
Antimicrobial agents and chemotherapy 61 (4), e02329-16, 2017
412017
Fungal infection in heart-lung transplant recipients receiving single-agent prophylaxis with itraconazole
D Hayes Jr, AM Ball, HM Mansour, CA Martin, JD Flynn
Exp Clin Transplant 9 (6), 399-404, 2011
232011
Fulminant invasive pulmonary aspergillosis after a near-drowning accident in an immunocompetent patient
KL Ratermann, BJ Ereshefsky, EL Fleishaker, AC Thornton, KP Buch, ...
Annals of pharmacotherapy 48 (9), 1225-1229, 2014
192014
Utilizing Monte Carlo Simulations to optimize institutional empiric antipseudomonal therapy
SJ Tennant, DR Burgess, JM Rybak, CA Martin, DS Burgess
Antibiotics 4 (4), 643-652, 2015
162015
Optimizing beta-lactam pharmacodynamics against Pseudomonas aeruginosa in adult cystic fibrosis patients
RZ Thompson, CA Martin, DR Burgess, WC Rutter, DS Burgess
Journal of Cystic Fibrosis 15 (5), 660-663, 2016
142016
Benefits of a 24-hour inhouse on-call program for pharmacy residents
KW Mcconeghy, PS Winstead, AM Cook, CA Martin, KA Weant, JD Flynn
American Journal of Health-System Pharmacy 69 (24), 2160-2164, 2012
102012
Comparison of ß-lactam plus aminoglycoside versus ß-lactam plus fluoroquinolone empirical therapy in serious nosocomial infections due to Gram-negative bacilli
BJ Ereshefsky, MN Al-Hasan, Y Gokun, CA Martin
Journal of Chemotherapy 29 (1), 30-37, 2017
62017
Effect of Clopidogrel Treatment on the Incidence and Severity of Community Acquired Pneumonia: Results of a Five-Year Cohort Study
AK Gross, SP Dunn, DJ Feola, CA Martin, SS Smyth
Circulation 122 (Suppl 21), A19964-A19964, 2010
12010
Syphilis: Here Today...Gone Tomorrow?
C Martin
Pharmacotherapy Casebook, 11th ed., 2019
2019
Erratum for Rutter et al., Nephrotoxicity during vancomycin therapy in combination with piperacillin-tazobactam or cefepime
WC Rutter, JN Cox, CA Martin, DR Burgess, DS Burgess
Antimicrobial agents and chemotherapy 61 (4), 2017
2017
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20